Is GBIO or VYM a better dividend investment in 2026?

GBIO currently yields 37.45% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: GBIO offers higher current income.

What is the dividend yield difference between GBIO and VYM?

GBIO has a forward dividend yield of 37.45% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 35.04 percentage points.

Home › Compare › GBIO vs VYM

GBIO vs VYM: Dividend Comparison 2026

GBIO yields 37.45% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GBIO wins by $173.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

GBIO

● Live price

37.45%

Share price

$5.34

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$201.6K

Annual income

$32,248.55

Full GBIO calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — GBIO vs VYM

📍 GBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GBIO	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GBIO + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GBIO pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBIO

Annual income on $10K today (after 15% tax)

$3,183.52/yr

After 10yr DRIP, annual income (after tax)

$27,411.27/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, GBIO beats the other by $27,174.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBIO + VYM for your $10,000?

GBIO: 50%VYM: 50%

100% VYM50/50100% GBIO

Portfolio after 10yr

$114.7K

Annual income

$16,263.54/yr

Blended yield

14.17%

📊

Analyst Conviction Gap

Where Wall Street is split right now

GBIO

No analyst data

Price Target

$5.25

-1.7% upside vs current

Range: $5.00 — $5.50

Altman Z

-9.1

Piotroski

1/9

VYM

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBIO buys

VYM buys

Politician	Chamber	Ticker	Type	Amount	Date
Carol Devine Miller	🏢 House	$VYM	▲ Buy	$15,001 - $50,000	2022-11-02

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGBIOVYM

Forward yield	37.45% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$201.6K ✓	$27.8K
Annual income after 10y	$32,248.55 ✓	$278.55
Total dividends collected	$148.7K ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: GBIO vs VYM ($10,000, DRIP)

Year	GBIO Portfolio	GBIO Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$14,445	$3,745.32	$11,151	$241.44	+$3.3K → GBIO
2	$20,513	$5,056.29	$12,413	$246.79	+$8.1K → GBIO
3	$28,659	$6,710.36	$13,794	$251.79	+$14.9K → GBIO
4	$39,427	$8,761.91	$15,306	$256.47	+$24.1K → GBIO
5	$53,452	$11,265.44	$16,960	$260.84	+$36.5K → GBIO
6	$71,468	$14,273.72	$18,768	$264.92	+$52.7K → GBIO
7	$94,307	$17,835.96	$20,745	$268.71	+$73.6K → GBIO
8	$122,904	$21,996.02	$22,905	$272.24	+$100.0K → GBIO
9	$158,298	$26,790.73	$25,265	$275.51	+$133.0K → GBIO
10	$201,627	$32,248.55	$27,842	$278.55	+$173.8K → GBIO

GBIO vs VYM: Complete Analysis 2026

GBIO — Stock

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Full GBIO Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this GBIO vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBIO vs SCHD GBIO vs JEPI GBIO vs O GBIO vs KO GBIO vs MAIN GBIO vs VIG GBIO vs DGRO GBIO vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.